Previously, we found that endogenously produced pro-inflammatory molecules, advanced glycation end products (AGEs), interact with tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and attenuate its immunomodulatory function. In the present study, to elucidate the mechanism by which AGEs attenuate TWEAK function, we searched for regions responsible for TWEAK-AGE interaction using TWEAK deletion mutants. Pull-down assays with the TWEAK mutants and AGEs revealed that the C-terminal half of TWEAK, which is the region essential for receptor stimulation, was required for this interaction. On the other hand, the N-terminal deletion mutants did not exhibit a significant decrease in AGE binding. Moreover, a moderate decrease in the AGE binding by double-deletion in quartered C-terminal half regions and a substantial decrease by triple-deletion in this region were observed. In addition, full-length TWEAK stimulated IL-8 gene expression in endothelial EA.hy.926 cells, whereas the triple-deletion mutant lost much of this activity, suggesting that the TWEAK-AGE interaction sites overlap with the region needed to exert normal function of TWEAK. Our present findings may help to elucidate the pathophysiological roles of the TWEAK-AGE interaction for prevention and treatment of AGE-related inflammatory diseases. C 2018
Introduction
Tumor necrosis factor like weak inducer of apoptosis (TWEAK) belongs to the TNF superfamily of cytokines and was reported to function in inflammatory regulation, cell growth or death, angiogenesis, tissue regeneration, and tumor development in a cell type specific or tissue-specific manner [1] . Unlike other TNF superfamily members, the TWEAK gene is expressed abundantly in most tissues, suggesting that TWEAK is a constitutively functioning cytokine [2] . TWEAK is initially expressed in a transmembrane form and is cleaved to generate a soluble form [1] . Soluble TWEAK forms trimer molecules and acts by binding to its cell surface receptor, fibroblast growth factor-inducible 14 (Fn14), and their engagement triggers the above-mentioned functions via activation of several intracellular signaling pathways including the NF-κB pathway [3] [4] [5] . The amount of TWEAK in the blood was reported to be correlated with the severity of atherosclerosis, diabetes, heart failure, and some autoimmune diseases, suggesting that the changes in the activity of this cytokine are involved in the molecular mechanisms underlying these diseases [6] [7] [8] [9] .
In our previous study, we found that TWEAK directly bound advanced glycation end products (AGEs) [10] . AGEs are heterogeneous inflammatory molecules formed nonenzymatically in vivo from reducing sugar or its metabolites with the free amino groups of biomolecules such as proteins and lipids. Increased formation and accumulation of AGEs was demonstrated to be correlated with aging, hyperglycemia, and some inflammatory diseases, indicating the possible involvement of AGEs in their pathogenesis [11] [12] [13] [14] . However, the mechanism by which AGEs contribute to the pathogenesis remains unclear. One possible explanation for this mechanism is that AGEs act as if pro-inflammatory cytokines via cell-surface receptor, receptor for AGEs (RAGE). AGE-RAGE interaction is reported to activate inflammatory responses, which may lead to the above-mentioned diseases [15] . On the other hand, in the cell which was not responsive to AGEs, we found that the interaction of TWEAK with AGEs attenuated the functions of TWEAK, suggesting that the accumulation of AGEs inhibits the normal activity of TWEAK. This finding suggests a novel AGEs action that causes inflammatory diseases by disrupting normal function of cytokines.
In the present study, we searched for regions in TWEAK responsible for interaction with AGEs, and discuss the pathophysiological roles of TWEAK-AGE interaction in AGE-related inflammatory diseases.
Materials and Methods

Materials
Recombinant human TWEAK was purchased from PeproTech (Rocky Hill, NJ, USA). Cobalt-coated magnetic beads were from Life Technologies (Gaithersburg, MD, USA). The In-Fusion HD cloning kit and Primestar HS DNA Polymerase were from Takara Bio (Kusatsu, Japan). The Zip Competent Cells BL21 (DE3) were from Biodynamics laboratory (Tokyo, Japan). Total RNA purification kits were from GMbiolab (Taichung, Taiwan). Other chemicals used were of analytical grade and obtained from standard sources.
Glyceraldehyde-modified bovine serum albumin (AGEs) and the monoclonal antibody specific for AGEs were prepared as previously described [10, 16, 17] .
Construction of expression vectors
The N-terminally His-tagged human TWEAK expression vector was constructed in the previous study [10] . Using this vector as the template, the expression vectors of TWEAK deletion mutants were constructed with the In-Fusion HD cloning kit or inverse PCR. In the present study, based on the soluble form of human TWEAK (97Lys to 249His of the transmembrane form), four N-terminal deletion mutants ( N1 lacking 97Lys to 116Arg, N1-2 lacking 97Lys to 136Ala, N1-3 lacking 97Lys to 156Thr, and N1-4 lacking 97Lys to 176Tyr), four C-terminal deletion mutants ( C1 lacking 232Ala to 249His, C1-2 lacking 212Val to 249His, C1-3 lacking 192Leu to 249His, and C1-4 lacking 172Gly to 249His), three C-terminal double-deletion mutants ( C1/C4 lacking 172Gly to 191Cys plus 232Ala to 249His, C2/C4 lacking 172Gly to 191Cys plus 212Val to 231Trp, and C3/C4 lacking 172Gly to 211Gln), and the C-terminal triple-deletion mutants, C1/C2/C4 lacking 172Gly to 191Cys plus 212Val to 249His, were generated. The forward and reverse primers used are shown in Table 1 . The sequences of all constructs were verified by DNA sequencing (Eurofins Genomics).
Expression of recombinant proteins and pull-down assays
The expression vectors were introduced into the Escherichia coli BL21 (DE3). Expression of the recombinant proteins was induced according to the manufacturer's instructions. Twenty-four hours after induction of recombinant protein expression, the cells were collected by centrifugation. The cells were then suspended in denaturing buffer (50 mM sodium phosphate, 300 mM NaCl, 6 M guanidine-HCl, pH 8), sonicated, and then centrifuged to remove insoluble cellular debris. For the pull-down assays, His-tagged recombinant proteins were purified using cobalt-coated magnetic beads according to the manufacturer's instructions. The proteins bound to beads were incubated with AGEs in wash buffer at room temperature for 30 min. The beads were then washed with wash buffer, and proteins bound to the beads were lysed in 1 × Laemmli sample buffer (2% SDS, 5% 2-mercaptoethanol, 5% sucrose, and 62.5 mM Tris-HCl, pH 6.8, 0.002% bromophenol blue). Prior to Western blotting, SDS-PAGE followed by Coomassie Brilliant Blue staining was used to confirm that the same amount of His-tagged recombinant protein was used for each pull-down assay. The protein samples were then analyzed by Western blotting, which was performed as previously described [10] .
Cell culture and semiquantitative real-time RT-PCR
EA.hy.926 cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal calf serum at 37
• C in humidified air containing 5% CO 2 . Total RNA was isolated from the cells cultured under each condition using total RNA isolation kits. The concentration and purity of the extracted total RNA were assessed using the 260/280 nm absorbance ratio. Using these RNA samples, real-time RT-PCR was performed as previously described [10] .
Statistical analyses
The statistical analysis across multiple groups was performed using Dunnett's test. Analyses were performed using R (version 3.1.3, The R Foundation for Statistical Computing). P-values < 0.05 were considered significant. All data were presented as the mean ± standard error.
Results
The regions responsible for interaction with AGEs are located in the C-terminal half of TWEAK
To identify the minimum regions of TWEAK needed for interaction with AGEs, we prepared a series of TWEAK mutants whose The expression vectors for C1/C4, C2/C4, and C1/C2/C4 were constructed by stepwise inverse PCR using the primers used for C1, C2, or C4 expression vectors, and C4 expression vector or C1-2 expression vector as a template. Underlined and bold letters represent the vector sequence or inserted stop codon, respectively. a The expression vectors for these mutants were constructed by conventional PCR using the above primers and previously constructed TWEAK expression vector as a template with the in-fusion HD cloning kit. b The expression vectors for these mutants were constructed by inverse PCR using the above primers and TWEAK expression vector.
N-or C-terminal amino acid sequences were additively deleted at roughly every 20 amino acid residues, which split the N-or C-terminal halves into approximate quarters (Fig. 1A) . First, recombinant soluble forms of human TWEAK (TWEAK full) was confirmed to interact with AGEs by pull-down assay (Fig. 1B) . AGEs used in the present study exhibit diverse molecular pattern (Fig. 1B, right lane) . In accordance with the previous report [10] , a similar molecular pattern was found in the sample pulldowned by TWEAK full-immobilized beads, indicating TWEAK full interacted with AGEs. On the other hand, a small portion of molecules were found in the sample from vehicle-treated beads, representing AGEs bound to beads themselves. Using this method, we next tested whether the N-terminal deletion mutants interacted with AGEs. The N-terminal half of TWEAK was found to not be involved in TWEAK-AGE interaction (Fig. 1C) . We next tested the C-terminal region of TWEAK using the same method. The results indicated that stepwise deletion of the C1 to C3 region of TWEAK did not alter TWEAK-AGE interaction, but the deletion of the C1 to C4 region ( C1-4) significantly attenuated this interaction, suggesting that TWEAK interacts with AGEs through the C4 region (Fig. 1D ).
The C4 region was not sufficient for AGE interaction
To clarify the contribution of the C4 region to TWEAK-AGE interaction, we next generated deletion mutants lacking the C2, C3, or C4 region alone ( C2, C3, and C4, y Fig. 2A ). Using these mutants and the mutant lacking the C1 region ( C1, Fig. 1A ), the AGE pull-down assay was performed. As shown in Fig. 2B , all mutants, including C4, interacted with AGEs similarly with native TWEAK, suggesting that neither C4 nor the other regions alone are sufficient for AGE interaction.
Multiple regions of the C-terminal half of TWEAK are essential for AGE interaction
As the C-terminal regions (C1-4) alone were not sufficient to interact with AGEs, we next generated double-deletion mutants lacking regions C1 plus C4 ( C1/C4), C2 plus C4 ( C2/C4), or C3 plus C4 ( C3/C4) ( Fig. 2A) , and performed a pull-down assay. The mutant C3/C4 interacted with AGEs similarly with native TWEAK, whereas the interaction was attenuated using the mutants C1/C4 and C2/C4 (Fig. 2C) . However, in these cases, broad smear bands representing pulled-down AGEs were weakly detected, suggesting that these mutants still had residual ability to interact with AGEs. Therefore, we generated a triple-deletion mutant that lacked regions C1, C2, and C4 ( C1/C2/C4, Fig. 3A ). The mutant C1/C2/C4 no longer interacted with AGEs, similar with the mutant C1-4 ( Fig. 3B) , suggesting that multiple C-terminal regions, except for region C3, are essential for TWEAK-AGE interaction.
The function of mutant TWEAK C1/C2/C4 was significantly attenuated, but not inhibited by AGEs
In accordance with the previous report [10] , TWEAK stimulated IL-8 gene expression and this function of TWEAK was attenuated by the co-addition of AGEs in EA.hy.926 cells (Fig. 4A) .
FIG. 1
The interaction of AGEs with TWEAK mutants lacking the N-or C-terminal half. (A) Schematic diagram of the full-length soluble form of human TWEAK and of N-or C-terminally deletion mutants. (B) The His-tagged full-length soluble form of TWEAK (TWEAK full) immobilized on cobalt-coated beads or beads treated with vehicle (Vehicle) was incubated with 1,000 μg/mL AGEs. The amount of AGEs bound to the beads or 500 ng of AGEs alone (AGEs) was visualized by Western blotting using the anti-AGE antibody. (C and D) The interaction of AGEs with the His-tagged full-length soluble form of TWEAK (TWEAK full), His-tagged four N-terminal deletion mutants ( N1, N1-2, N1-3, and N1-4), or four C-terminal deletion mutants ( C1, C1-2, C1-3, and C1-4) was compared. The pull-down assays were performed as described in (B).
Under the same conditions, the effects of the triple-deletion mutant C1/C2/C4 and AGEs were evaluated. As shown in Fig.  4B , the stimulatory activity of the mutant C1/C2/C4 to increase IL-8 expression was attenuated and the co-addition of AGEs failed to alter the activity of the C1/C2/C4 mutant.
Discussion
The formation and accumulation of AGEs has been suggested to be involved in the pathogenesis of inflammatory diseases [11] [12] [13] [14] . However, the pathogenic mechanisms of AGEs are still only partially understood. Previously, we found that AGEs directly interacted with TWEAK and attenuated the function of this cytokine [10] . This raised the possibility that interaction of AGEs with some cytokines cause diseases by disrupting normal cytokine activity. To examine this possibility, the molecular mechanism of interaction between TWEAK and AGEs needs to be elucidated. Therefore, in the present study, we tried to identify the minimal regions of TWEAK responsible for interaction with AGEs.
Initially, we prepared TWEAK mutants whose amino acid residues were sequentially deleted from the N-or Cterminal, and quantitative analyses of interactions between the mutants and AGEs were performed by pull-down assay (Fig. 1C and D) . As a result, the C-terminal half of TWEAK was found to be involved in the interaction with AGEs (Fig.  1D) . To find the minimum region needed for interaction with AGEs, we prepared TWEAK mutants lacking single regions of the C-terminal half split into quarters. However, these singledeletion mutants still interacted with AGEs, demonstrating the involvement of multiple regions for AGE interaction (Fig. 2B) . Therefore, we next examined the interaction between AGEs and TWEAK mutants lacking multiple regions of the C-terminal. As compared with native TWEAK, moderate and substantial decreases in the interaction with AGEs were observed with two double-deletion mutants ( C1/C4 and C2/C4) and the
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FIG. 2
The interaction of AGEs with TWEAK mutants lacking 1 or 2 regions of the quartered C-terminal half. (A) Schematic diagram of His-tagged TWEAK deletion mutants lacking 1 or 2 regions of the quartered C-terminal half ( C1, C2, C3, C4, C1/C4, C2/C4, and C3/C4). (B and C) The interaction of AGEs with the His-tagged full-length soluble form of TWEAK (TWEAK full) or TWEAK deletion mutants described in (A) was compared.
The pull-down assays were performed as described in Fig. 1B. triple-deletion mutant ( C1/C2/C4), respectively (Figs. 2C and 3B). These results indicated that most of the C-terminal half of TWEAK (78 amino acid residues) is responsible for the interaction with AGEs. As a similar example, the recognition site of AGEs in RAGE, the endogenous pattern recognition receptor of AGEs, was also identified as multiple regions of the V domain consisting of 94 amino acid residues [18] . These findings suggested that the interaction of AGEs with endogenous proteins occurs via multiple relatively larger regions rather than by usual protein-protein interactions via a specific motif sequence. The reason for the larger interaction site may be the diverse structures of AGEs [19, 20] . To date, in addition to TWEAK, some functional proteins, such as IL-8 and C1q, were reported to interact with AGEs [10, 21] . Detailed investigations of these interactions will help to elucidate the mechanism by which AGEs contribute to the pathogenesis of inflammatory diseases.
We previously reported that TWEAK-AGE interaction inhibited TWEAK activity [10] . Briefly, native TWEAK induced IL-8 mRNA expression in EA.hy.926 cells, which were not responsive to AGEs, and this was dose-dependently inhibited by the co-addition of AGEs. In the present study, we found that the TWEAK mutant lacking most of the C-terminal half failed to interact with AGEs, but it remains to be clarified whether the triple-deletion mutant ( C1/C2/C4) retained its stimulatory activity even in the presence of AGEs. For this purpose, EA.hy.926 cells were stimulated with C1/C2/C4 alone or C1/C2/C4 plus AGEs, and IL-8 expression as an indicator of stimulatory activity was compared. As a result, the activity of C1/C2/C4 to increase IL-8 expression was attenuated, and the co-addition of AGEs had no significant effect on the activity of C1/C2/C4 (Fig. 4) .
These results are likely due to the relationship between the mechanism of action and structure of TWEAK. The structure of TWEAK was previously reported to be two antiparallel β-sheets linked by disulfide bonds [22] . Similar with other TNF superfamily member cytokines, TWEAK acts as a homo trimer [1] . One β-sheet faces the inside of the TWEAK trimer and is responsible for trimerization, and the other faces the outside. The inward-facing sheet is constituted by 5 β-strands, and two of them are located separately at the C-terminal region of ( C1-4) was assessed. The pull-down assays were performed as described in Fig. 1B. TWEAK, which interacts with AGEs. Due to the absence of the region responsible for trimerization, the complex formation of C1/C2/C4 was considered to be attenuated, resulting in the decrease in TWEAK activity. Furthermore, as the region deleted in C1/C2/C4 was found to be the interaction site of TWEAK with AGEs, TWEAK-AGE interaction may shield the region responsible for trimerization, resulting in inhibition of the normal activity of native TWEAK.
FIG. 3
The interaction of AGEs with the TWEAK mutant lacking three regions of the quartered C-terminal half. (A) Schematic diagram of His-tagged TWEAK deletion mutants lacking three regions of the quartered C-terminal half ( C1/C2/C4). (B) The interaction of AGEs with the His-tagged full-length soluble form of TWEAK (TWEAK full), TWEAK deletion mutants described in (A), or the mutant lacking C-terminal half
In addition, the decreased activity by C1/C2/C4 is likely related to the interaction of TWEAK with its receptor, Fn-14. The amino acid residues in TWEAK essential for interaction with Fn-14 have been clarified [22] , and they are located in the region deleted in C1/C2/C4. Thus, the binding between native TWEAK and AGEs via this region likely inhibited TWEAK-Fn14
FIG. 4
The interaction, resulting in the decreased biological activity of native TWEAK.
One limitation of this study is that the present findings were obtained using recombinant proteins produced by an E. coli expression system. The conformation and/or posttranslational modifications of these proteins may be different from those of eukaryotic proteins, even though there were likely functional. Therefore, the present findings will benefit from a confirmation study using eukaryotic proteins.
In the present study, we found that TWEAK interacted with AGEs via multiple regions in the C-terminal half. In addition, the region involved in TWEAK-AGE interaction was suggested to be responsible for the trimerization of TWEAK and/or TWEAK-Fn14 interaction, indicating that AGEs may attenuate the activity of TWEAK by shielding the region essential for its function. To further verify the present findings, more detailed studies are currently under way.
